Vés al contingut

Marta Villalba Montaner

Institucions de les que formen part

Investigador predoctoral
Vall Hebron Institut de Recerca
Marta  Villalba  Montaner

Projectes

CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY RELATED MALIGNANCIES

IP: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY
Col·laboradors: Marta Villalba Montaner, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY, Bárbara Tazón Vega, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY, Silvia Saumell Tutusaus, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY
Entitat finançadora: Instituto de Salud Carlos III
Finançament: 215380
Referència: PI20/00881
Durada: 01/01/2021 - 31/12/2023

Subscriu-te als nostres butlletins i forma part de la vida del Campus

El Vall d’Hebron Barcelona Hospital Campus és un parc sanitari de referència mundial on assistència, recerca, docència i innovació es donen la mà.